Susquehanna International Group, LLP Viking Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,115,105 shares of VKTX stock, worth $45.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,115,105
Previous 1,404,715
20.62%
Holding current value
$45.9 Million
Previous $74.5 Million
5.19%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
65.6MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$418 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$248 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$192 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$87.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$77.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.16B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...